SYMBYX at WPC2023: Researcher Anita Saltmarche speaks on light therapy for Parkinson's disease

Researcher Anita Saltmarche (BScN, MHSc) is a Co-Lead Researcher on a Parkinson's Trial that is currently underway in Canada. Anita was interviewed at the World Parkinson's Congress at the SYMBYX booth, and asked to give her thoughts on light therapy. Why is she excited by it? What does it do? How does she think this would benefit the Parkinson's community?
SYMBYX is a med-tech company that pioneers laser light therapy devices for chronic conditions such as Parkinson's disease. We have the first ever medically approved laser light therapy device for Parkinson's, perfect for at-home treatment.
Please visit symbyxbiome.com/ for more information.
SYMBYX medical laser devices are CE- and ARTG listed. SYMBYX devices are subject to different regulations, permits and clearances in each country and are not available for sale in all countries, including the U.S.
#gutbrainhealth #parkinsonsdisease #lighttherapy #redlighttherapy #infraredlighttherapy #photobiomodulation

[@MLStanleyK]

I have been using the hand held laser therapy SYMBYX device for almost a year and have felt a big decrease in some of the symptoms, but more than anything, simply have felt better in a general way! Thank you!

[@symbyxbiome]

We are so glad to hear that you feel better! Thank you for your comment.